4.0 Article

STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery Studies

Related references

Note: Only part of the references are listed.
Article Pathology

Short-term Toxicity Study of ST-20 (NSC-741804) by Oral Gavage in Sprague-Dawley Rats

Pramod S. Terse et al.

TOXICOLOGIC PATHOLOGY (2011)

Article Biotechnology & Applied Microbiology

Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

Frank Dieterle et al.

NATURE BIOTECHNOLOGY (2010)

Article Biotechnology & Applied Microbiology

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies

Vishal S. Vaidya et al.

NATURE BIOTECHNOLOGY (2010)

Article Toxicology

Biomarkers of Drug-Induced Skeletal Muscle Injury in the Rat: Troponin I and Myoglobin

Jeffrey D. Vassallo et al.

TOXICOLOGICAL SCIENCES (2009)

Review Pharmacology & Pharmacy

Strategic approach to fit-for-purpose biomarkers in drug development

John A. Wagner

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)

Article Chemistry, Multidisciplinary

Fit-for-purpose method development and validation for successful biomarker measurement

JW Lee et al.

PHARMACEUTICAL RESEARCH (2006)

Article Veterinary Sciences

Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies

L Boone et al.

VETERINARY CLINICAL PATHOLOGY (2005)